August 24, 2018 — In a small study of military personnel who had suffered head trauma and had reported memory and mood ...
June 13, 2018 — A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron ...
May 17, 2018 — A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
May 9, 2018 — Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a ...
May 3, 2018 — BWX Technologies Inc. signed a definitive agreement to acquire Sotera Health’s Nordion medical isotope ...
April 10, 2018 — Researchers have developed a new imaging agent that could help guide and assess treatments for people ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear ...
February 21, 2018 — Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the ...
February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took ...
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallmark ...
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new radiotracer, 2 ...
December 28, 2017 — In the December featured basic science article in The Journal of Nuclear Medicine, Belgian ...
October 27, 2017 — The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a ...
August 30, 2017 — ARTMS Products Inc. signed a strategic partnership with GE Healthcare around ARTMS’ proprietary ...
August 16, 2017 — In the featured translational article in the August issue of The Journal of Nuclear Medicine ...
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET) radiotracer that is ...
July 7, 2017 — Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are ...
June 20, 2017 — Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F ...
May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the ...
May 15, 2017 — Blue Earth Diagnostics announced that the Trial Steering Committee recommended further recruitment be ...
August 24, 2018 